| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
eukaryotic translation termination factor 1 | 0.780 | 0.269 | 1.00 |
|
disease | 0.100 | None | 1.000 | 6 | 2 | 2014 | 2019 | ||||||||
|
THO complex 7 | 1.000 | 0.038 | 6.1E-03 |
|
disease | 0.100 | None | 1.000 | 5 | 2 | 2014 | 2019 | ||||||||
|
long intergenic non-protein coding RNA 2551 | 1.000 | 0.038 |
|
disease | 0.100 | None | 1.000 | 5 | 3 | 2014 | 2019 | |||||||||
|
protein phosphatase 1 regulatory subunit 16B | 0.821 | 0.308 | 1.00 |
|
disease | 0.100 | None | 1.000 | 5 | 1 | 2014 | 2019 | ||||||||
|
protein kinase D1 | 0.531 | 0.846 | 6.6E-07 |
|
disease | 0.100 | None | 1.000 | 5 | 2 | 2014 | 2019 | ||||||||
|
selenoprotein H | 0.821 | 0.192 | 1.3E-03 |
|
disease | 0.100 | None | 1.000 | 5 | 1 | 2014 | 2019 | ||||||||
|
immunoglobulin superfamily member 9B | 0.821 | 0.192 | 0.87 |
|
disease | 0.100 | None | 1.000 | 5 | 2 | 2014 | 2019 | ||||||||
|
GID complex subunit 4 homolog | 1.000 | 0.038 | 0.92 |
|
disease | 0.100 | None | 1.000 | 5 | 2 | 2014 | 2019 | ||||||||
|
secondary ossification center associated regulator of chondrocyte maturation | 0.931 | 0.038 | 0.60 |
|
disease | 0.100 | None | 1.000 | 5 | 1 | 2013 | 2019 | ||||||||
|
tripartite motif containing 26 | 0.705 | 0.577 | 0.18 |
|
disease | 0.100 | None | 1.000 | 5 | 3 | 2011 | 2019 | ||||||||
|
cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene | 0.805 | 0.346 |
|
disease | 0.100 | None | 1.000 | 5 | 7 | 2015 | 2019 | |||||||||
|
proline rich and Gla domain 2 | 1.000 | 0.038 | 9.1E-07 |
|
disease | 0.100 | None | 1.000 | 5 | 1 | 2014 | 2019 | ||||||||
|
enhancer of polycomb homolog 2 | 0.743 | 0.500 | 1.00 |
|
disease | 0.100 | None | 1.000 | 4 | 3 | 2015 | 2019 | ||||||||
|
capping protein regulator and myosin 1 linker 1 | 0.722 | 0.500 | 3.4E-02 |
|
disease | 0.100 | None | 1.000 | 4 | 4 | 2015 | 2019 | ||||||||
|
RERE antisense RNA 1 | 0.890 | 0.077 |
|
disease | 0.100 | None | 1.000 | 4 | 3 | 2015 | 2019 | |||||||||
|
protein kinase cGMP-dependent 1 | 0.603 | 0.769 | 1.00 |
|
disease | 0.100 | None | 1.000 | 4 | 1 | 2015 | 2019 | ||||||||
|
GRB10 interacting GYF protein 2 | 0.711 | 0.269 | 1.00 |
|
disease | 0.100 | None | 1.000 | 4 | 2 | 2014 | 2019 | ||||||||
|
A-kinase anchoring protein 6 | 0.695 | 0.538 | 1.00 |
|
disease | 0.100 | None | 1.000 | 4 | 3 | 2015 | 2019 | ||||||||
|
cytoplasmic polyadenylation element binding protein 1 | 0.638 | 0.538 | 1.00 |
|
disease | 0.100 | None | 1.000 | 4 | 2 | 2015 | 2019 | ||||||||
|
POM121 transmembrane nucleoporin like 2 | 0.861 | 0.192 | 0.33 |
|
disease | 0.100 | None | 1.000 | 4 | 3 | 2009 | 2019 | ||||||||
|
p21 (RAC1) activated kinase 6 | 0.729 | 0.385 | 4.3E-05 |
|
disease | 0.100 | None | 1.000 | 4 | 2 | 2014 | 2019 | ||||||||
|
psoriasis susceptibility 1 candidate 1 | 0.656 | 0.731 | 2.7E-04 |
|
disease | 0.100 | None | 1.000 | 4 | 3 | 2015 | 2019 | ||||||||
|
HDAC2 and HS3ST5 antisense RNA 2 | 1.000 | 0.038 |
|
disease | 0.100 | None | 1.000 | 4 | 3 | 2013 | 2019 | |||||||||
|
BCL2 interacting protein 3 like | 0.636 | 0.654 | 0.15 |
|
disease | 0.100 | None | 1.000 | 4 | 3 | 2015 | 2019 | ||||||||
|
phospholipase C eta 2 | 0.861 | 0.231 | 1.8E-18 |
|
disease | 0.100 | None | 1.000 | 4 | 1 | 2014 | 2019 |